Citigroup Argues KV Pharma Knew ARS Risks

Law360, New York (August 25, 2009, 3:57 PM EDT) -- Citigroup Global Markets Inc. has urged a court to toss a suit brought by KV Pharmaceutical Co. in the wake of the auction rate securities fiasco, saying the drugmaker cannot use the legal system as insurance against a bad investment.

In a motion to dismiss filed Monday in the U.S. District Court for the Southern District of New York, the brokerage arm of Citigroup Inc. said KV was a sophisticated investor that could not “credibly argue that it was oblivious” to the risks of ARS....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.